PLB-1001

• Description:

  PLB-1001 (Bozitinib, PLB1001, CBI-3103, CBT-101) is a potent, highly selective, ATP-competitive, BBB-permeable MET kinase inhibitor, potently inhibits MET activity by 95.1% at 2 uM.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  424.391

• Molecular Formula:

  C20H15F3N8

• Notes:

  Research use only, not for human use.

• Receptor:

  C-Met/HGFR

• CAS Number:

  1440964-89-5